These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 3882114

  • 1. A preliminary trial of a novel form of active immunotherapy in squamous cell carcinoma of the lung.
    Lachmann PJ, Grant RM, Freedman LS, Sikora K, Bleehen NM.
    Br J Cancer; 1985 Mar; 51(3):415-7. PubMed ID: 3882114
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunotherapy of lung cancer. I. Review of clinical trials in non-small cell histologic types.
    Mikulski SM, McGuire WP, Louie AC, Chirigos MA, Muggia FM.
    Cancer Treat Rev; 1979 Sep; 6(3):177-90. PubMed ID: 394836
    [No Abstract] [Full Text] [Related]

  • 4. Perspectives in immunotherapy of lung cancer.
    Hersh EM, Gutterman JU, Mavligit GM.
    Cancer Treat Rev; 1974 Mar; 1(1):65-80. PubMed ID: 4471091
    [No Abstract] [Full Text] [Related]

  • 5. Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).
    Jansen HM, The TH, de Gast GC, Esselink MT, van der Wal AM, Orie NG.
    Thorax; 1978 Aug; 33(4):429-38. PubMed ID: 358479
    [Abstract] [Full Text] [Related]

  • 6. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
    Warren SE, Crispen RG, Nika B.
    Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Trial of BCG immunotherapy in the treatment of resectable sequamous cell carcinoma of the bronchus (stages I and II).
    Pouillart P, Mathé G, Palangie T, Schwarzenberg L, Huguenin P, Morin P, Gautier H, Baron A.
    Recent Results Cancer Res; 1977 Jul; (62):151-5. PubMed ID: 341247
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung].
    Fujisawa T.
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):13-20. PubMed ID: 2981513
    [Abstract] [Full Text] [Related]

  • 11. [Therapeutic experience in lung cancer using BCG cell-wall skeleton--with special reference to cases of pleural effusion].
    Morishita M.
    Kekkaku; 1977 Oct; 52(10):531-2. PubMed ID: 599772
    [No Abstract] [Full Text] [Related]

  • 12. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
    Hadźiev S, Mandulova P, Kavaklieva-Dimitrova J, Penev K, Spassova M, Madźarova S.
    Neoplasma; 1982 Oct; 29(1):93-110. PubMed ID: 6280082
    [Abstract] [Full Text] [Related]

  • 13. [Immunotherapy of carcinoma of the lung].
    Sega E, Mineo TC, Rea SR, Sega FM, Ricci C.
    Recenti Prog Med; 1978 Mar; 64(3):293-309. PubMed ID: 351751
    [No Abstract] [Full Text] [Related]

  • 14. [Immunotherapy with BCG-CWS (cell-wall skeleton) in patients with primary lung cancer (author's transl)].
    Takano T, Morishita M, Yamamoto M, Yamagata K, Takada K.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Nov; 15(11):769-74. PubMed ID: 606901
    [No Abstract] [Full Text] [Related]

  • 15. Effect of BCG cell-wall skeleton immunotherapy on the peripheral blood lymphocytes in patients with lung cancer after radiotherapy.
    Nishikawa H, Yasaki S, Yoshimoto T, Sakatani M, Itoh M, Masuno T, Namba M, Ogura T, Hirao F, Azuma I, Yamamura Y.
    Gan; 1978 Dec; 69(6):819-24. PubMed ID: 750274
    [Abstract] [Full Text] [Related]

  • 16. Specific and nonspecific immunotherapy as an adjunct to curative surgery for cancer of the lung.
    Hollinshead AC, Stewart TH.
    Yale J Biol Med; 1981 Dec; 54(5):367-79. PubMed ID: 7039148
    [Abstract] [Full Text] [Related]

  • 17. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E, Haim N, Segal R, Veseley Z, Mekori T.
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [Abstract] [Full Text] [Related]

  • 18. New method of immunotherapy for lung cancer.
    Holmes EC, Ramming KP, Mink J, Coulson WF, Morton DL.
    Lancet; 1977 Sep 17; 2(8038):586-7. PubMed ID: 71401
    [No Abstract] [Full Text] [Related]

  • 19. Regional immunotherapy in resectable squamous cell lung carcinoma. Analysis of a randomized study.
    Roeslin N, Lang JM, Morand G, Wihlm JM, Witz JP.
    Cancer Immunol Immunother; 1982 Sep 17; 13(3):174-5. PubMed ID: 6925982
    [Abstract] [Full Text] [Related]

  • 20. Immunologic alterations and active aspecific immunotherapy in lung cancer patients.
    Banna P, Murabito R, Saggio A, Cordopatri F, Riggi M, Campo ME, Cinà C, Latteri S.
    Ital J Surg Sci; 1983 Sep 17; 13(2):133-7. PubMed ID: 6195126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.